Immuno-Oncology Assets

“Sorrento’s immuno-oncology platform started with the generation of a vast antibody library using our proprietary G-MAB™ Technology. It is one of the largest and most diverse libraries of fully human antibodies in the biopharmaceutical industry”
– Dr. Henry Ji, CEO

 
View Immuno-Oncology Assets

Pain Management Assets

“Pain is ubiquitous in most malignant forms of cancer. The options we can offer to terminally ill cancer patients are not acceptable by current emotional and technological standards. We have to find better non-opioid non-addictive ways to address intractable cancer pain.”
– Dr. Alexis Nahama, Vice President of Corporate Development and President Ark Animal Health

View Pain Management Assets